8.95
0.27 (3.11%)
| Penutupan Terdahulu | 8.68 |
| Jumlah Dagangan | 171,085 |
| Harga / Jualan (P/S) | 5.46 |
| Harga / Buku (P/B) | 8.86 |
| Julat 52 Minggu |
| Margin Keuntungan | -63.24% |
| Margin Operasi (TTM) | -79.16% |
| EPS Cair (TTM) | -0.980 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -9.10% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 52.12% |
| Nisbah Semasa (MRQ) | 10.47 |
| Aliran Tunai Operasi (OCF TTM) | -24.17 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -8.84 M |
| Pulangan Atas Aset (ROA TTM) | -21.77% |
| Pulangan Atas Ekuiti (ROE TTM) | -52.88% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | Sight Sciences, Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -4.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 2.0 |
| Purata | -0.83 |
|
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 20.87% |
| % Dimiliki oleh Institusi | 50.88% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Kck Ltd. | 30 Sep 2025 | 4,374,975 |
| Americana Partners, Llc | 30 Jun 2026 | 1,679,069 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |